Correction: Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation.

Zongren Zhao Jiawei Shen Long Zhang Lansheng Wang Haoyue Xu Yuhan Han Jun Jia Yang Lu Rutong Yu Hongmei Liu

Biomater Sci

Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou 221002, P. R. China. and Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, P. R. China.

Published: February 2021

Correction for 'Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation' by Zongren Zhao et al., Biomater. Sci., 2020, 8, 5306-5316, DOI: 10.1039/D0BM00338G.

Download full-text PDF	Source
http://dx.doi.org/10.1039/d1bm90016a	DOI Listing

Publication Analysis

Top Keywords

postoperative enzyme-responsive

enzyme-responsive hydrogels

hydrogels reversing

reversing temozolomide

temozolomide resistance

resistance reducing

reducing local

local recurrence

recurrence glioma

correction injectable

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!